The aim of this study was to explore clinical features of @entity1188 ( @entity1188 ) that may have a role in diagnosis and treatment in our @entity1 cohort and provide data on midterm renal functions. Medical records of @entity1 with diagnosis of acute @entity1188 , established by contrast enhanced computed tomography (CT) and at least 1 year follow-up data, who were hospitalized in our clinic between 1998 and 2012 were retrospectively reviewed; including descriptive data, clinical signs and symptoms, etiologic factors, laboratory findings, and prescribed treatments. @entity1 with solitary @entity1188 were treated with @entity117 ( @entity7943 ) only, whereas @entity1 with @entity955 ( @entity955 ) or multiple or global @entity1188 were treated with anticoagulants. Estimated Glomerular Filtration Rate (eGFR) referring to renal functions was determined by the @entity8 ( @entity8 ) formula. Twenty-seven renal units of 23 @entity1 with acute @entity1188 were identified. The mean age was 59.7      15.7 years. Fourteen @entity1 (60.8%) with @entity1188 had @entity955 ( @entity955 ) as an etiologic factor of which four had concomitant @entity5327 at diagnosis. At presentation, 20 @entity1 (86.9%) had elevated serum @entity880 dehydrogenase (LDH), 18 @entity1 (78.2%) had @entity491 , and 16 @entity1 (69.5%) had microscopic @entity811 . Two @entity1 with concomitant @entity5327 and @entity955 passed away during follow up. Mean eGFR was 70.8      23.2  mL/ @entity1009 .73  m(2) at admission and increased to 82.3      23.4  mL/ @entity1009 .73  m(2) at 1 year follow up. @entity1188 should be considered in @entity1 with persistent @entity812 or @entity490 , particularly if they are at high risk of @entity1031 . Antiplatelet and/or anticoagulant drugs are both effective treatment options according to the amplitude of the @entity1188 for preserving kidney functions.

Midterm renal functions following acute XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity8 :: ('MESH:D007674', 'Disease') :: ['MDRD', 'Modification of Diet in Renal Disease'] @entity1009 :: ('966', 'Gene') :: ['min/1'] @entity491 :: ('MESH:D007964', 'Disease') :: ['leukocytosis'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['acetylsalicylic acid'] @entity812 :: ('MESH:D021501', 'Disease') :: ['flank'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['renal infarction', 'infarct', 'RI'] @entity1031 :: ('MESH:D013923', 'Disease') :: ['thromboembolism'] @entity880 :: ('MESH:D019344', 'Chemical') :: ['lactate'] @entity955 :: ('MESH:D001281', 'Disease') :: ['atrial fibrillation', 'AF'] @entity490 :: ('MESH:D015746', 'Disease') :: ['abdominal pain'] @entity811 :: ('MESH:D006417', 'Disease') :: ['hematuria'] @entity7943 :: ('D001241', 'Chemical') :: ['ASA'] @entity5327 :: ('MESH:D065666', 'Disease') :: ['mesenteric ischemia']
@entity1188 :: (MESH:D007238,Disease) :: ['renal infarction']
